![Myriam Mendila](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Myriam Mendila
Directeur Technique/Scientifique/R&D chez
CUREVAC
Profil
Myriam Mendila currently works at CureVac NV, as Chief Scientific Officer, Head-R&D.
Dr. Mendila also formerly worked at Novartis Pharma AG, as Chief Medical Officer-Oncology.
Dr. Mendila received her doctorate degree from Hannover Medical School.
Postes actifs de Myriam Mendila
| Sociétés | Poste | Début |
|---|---|---|
| CUREVAC | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Myriam Mendila
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | - |
Formation de Myriam Mendila
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
